301333 fundamentals
An in-depth look to R&G PHARMASTUDIES operating, investing, and financing activities
301333 free cash flow for Q3 24 is 48.18 M CNY. For 2023, 301333 free cash flow was 197.74 M CNY and operating cash flow was 217.62 M CNY.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM